Abbott ARCHITECT cSystems ICT Module, REF 09D28-03. Product Usage: The ARCHITECT cSystems ICT...
FDA Device Recall #Z-1296-2019 — Class II — August 28, 2018
Recall Summary
| Recall Number | Z-1296-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 28, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Abbott Laboratories, Inc |
| Location | Irving, TX |
| Product Type | Devices |
| Quantity | 99 modules/kits |
Product Description
Abbott ARCHITECT cSystems ICT Module, REF 09D28-03. Product Usage: The ARCHITECT cSystems ICT (Integrated Chip Technology) is used for the quantitation of sodium, potassium, and chloride in human serum, plasma, or urine.
Reason for Recall
There is a potential to generate falsely elevated serum or plasma chloride results when using the product.
Distribution Pattern
Worldwide Distribution - US Nationwide in the states of AR, CA, CT, FL, IA, IN, LA, MA, MD, MS, NJ, NY, PA, SC, TX, VT, WA, and WV. There was government distribution and no military distribution. Foreign distribution was made to Australia, China, Hong Kong, and New Zealand.
Lot / Code Information
Lot No. 180326, Exp. 12/26/2018; UDI (01)00380740019327(17)181226(10)180326(21)180326301 through (01)00380740019327(17)181226(10)180326(21)180326399
Other Recalls from Abbott Laboratories, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0749-2022 | Class II | Alinity s System software version2.8.0, REF LN ... | Feb 3, 2022 |
| Z-2276-2021 | Class II | Alinity s System REF 06P16-01. An automated i... | Jul 12, 2021 |
| Z-1671-2020 | Class II | ARCHITECT C System Mixer - Product Usage: The A... | May 1, 2019 |
| Z-0971-2019 | Class II | ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-... | Jan 2, 2019 |
| Z-2755-2019 | Class II | APS Accelerator modular systems, 208-230 V-, 50... | Sep 7, 2018 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.